Clinical Trial Update: Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of different doses of bimekizumab in chronic plaque psoriasis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: UCB Biopharma S.P.R.L. | Conditions: Chronic Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2020-11-19